store umbilical cord blood: février 2014

lundi 24 février 2014

PUBLIC CORD BLOOD BANK

PUBLIC CORD BLOOD BANK

Héma-Québec collects, processes, analyzes and stores umbilical cord blood. There are currently more than 8,000 units of cord blood in Héma-Québec’s Public Cord Blood Bank ready to be used. In addition to meeting local and national needs, it contributes to international efforts to find stem cells for patients awaiting a transplant.

The organizational structure of Héma-Québec’s Public Cord Blood Bank includes:

a stem cell laboratory responsible for the qualification, processing and cryopreservation of cord blood units;
a team dedicated to recruiting and screening mothers.

Héma-Québec’s cord blood collection program is active in the following partner hospitals:
St. Mary’s Hospital Center
CHU Sainte-Justine Mother and Child University Hospital Center
Royal Victoria Hospital
CHU de Québec (mother-child centre)
Hôpital de la Cité-de-la-Santé de Laval
Centre hospitalier de LaSalle
Hôpital du Sacré-Cœur de Montréal
Lakeshore General Hospital.

Study uses cord blood stem cells in hearing loss treatment

Study uses cord blood stem cells in hearing loss treatment

When children fall and scrape their knee, their body begins an amazing repair process. Blood coagulates to form a protective cover and skin cells begin to regenerate. Add a kiss and a bandage and the knee is usually completely healed within a week or two. But what happens if that child is born with a more severe problem – such as a heart defect or hearing loss? As amazing as the human body can be, sometimes its natural healing process needs a little help to get started.

That's the impetus behind a study using umbilical cord blood to treat hearing loss in children. Florida Hospital for Children and Cord Blood Registry (CBR) are launching a FDA-regulated, Phase 1 safety study of the use of cord blood stem cells to treat children with sensorineural hearing loss.

cord blood graphResearchers are currently in the enrollment phase of the study. Ten children between the ages of 6 weeks and 6 years old will be treated using their own stored umbilical cord blood. Patients will receive one intravenous infusion of their own umbilical cord blood stem cells and return for follow-up at one month, six months and one year post-treatment.

Children with genetic deafness are ineligible for study participation. More information on study enrollment and criteria can be found at http://www.cordblood.com/stem-cell-research/cord-blood-research/hearing-loss

According to the Center for Hearing and Communication, approximately 3 million children in the United States have a hearing loss; 1.3 million of them are under the age of three. Children with sensorineural hearing loss experience problems or deformities with the cochlea (sensory) or the hearing nerve (neural) due to illness, birth defects, medication, noise or head trauma.

Although hearing aids and cochlear implants are effective means of treating sensorineural hearing loss in both children and adults, these instruments do not repair damaged hearing. If successful, cord blood stem cell treatment could repair the damage, leading to improved speech and language skills, social interaction, and cognitive learning abilities for children with acquired sensorineural hearing loss.
Cord Blood Registry is a cord banking company headquartered in San Bruno, California. Currently, the company participates in FDA-regulated clinical trials for autism, cerebral palsy, pediatric stroke and traumatic brain injury. This study marks the first for hearing loss treatment.

Researchers learned the benefits of using cord blood in 1988 when the first sibling-donor cord blood transplant was performed for a five-year-old child with Fanconi anemia. In 2002, they began exploring stem cells' ability to help the body heal itself. By 2005, clinical trials were in place to investigate newborn stem cell therapies for damaged tissue. Today, more than one million people have benefited from stem cell treatment for more than 80 different diseases.

Cord blood stem cells have documented success in treating leukemia, Multiple Sclerosis, Rheumatoid Arthritis, Hodgkins disease and Non-Hodgkins lymphoma to name a few. Researchers are hopeful cord blood will eventually be effective in the treatment of AIDS, heart disease, Alzheimer's, Parkinson's disease, spinal cord injury and stroke.

What makes stem cells so desirable? Stem cells are considered the body's "master cells" because they have the ability to create the different types of cells that make up human organs, blood, tissue and immune system. Stem cells, typically found in bone marrow and fat tissue, have the ability to divide and develop into any of the three main types of cells found in the blood: red blood cells, white blood cells and platelets.

Although cord blood stem cells have the same capacity as stem cells found in other parts of the body, there is less of a risk for transmitting infectious disease or being rejected by the host. They are also much easier and safer to collect.

Cord blood stem cells are different from the controversial embryonic stem cells, which require the destruction of a human embryo to obtain. Cord blood is collected with no risk to the mother or child and can be frozen and stored for many years. More than 200 hospitals actively collect cord blood from babies (with mother's consent).

Parents must make the decision to collect and store their baby's newborn stem cells immediately after birth. After the umbilical cord has been clamped and cut, the remaining blood in the umbilical cord is drawn into a collection bag. Costs include $2,000 for the procedure and approximately $125/year to store the baby's core blood. Parents may also choose to donate their cord blood to public storage banks. The American Academy of Pediatrics encourages public cord-blood donations; however, opposes private banking in most cases.

UMBILICAL CORD BLOOD RESEARCH A VALUE TOOL

UMBILICAL CORD BLOOD RESEARCH A VALUE TOOL

“I participated in a campaign on behalf of Dad Central for the Cord Blood Registry. I received promotional item to thank me for my participation.”

When I had my first child, I learned that there’s nothing more exciting and nerve racking than waiting for my baby to arrive. Recently, I learned that men can help to control things such and safety and the security of my family. One of those things is considering whether to bank or donate your newborn’s core blood stem cells.

Stem cells that are in a newborn’s umbilical cord have unique characteristics, other than are found in other parts of the body. Cord blood is rich in hematopoietic steam cells. HSC’s that are acquired from cord blood offer advantages compared to adult stem cells that come from bone marrow, and cord blood can be collected without posing risk to the mother or the newborn.

Because this information isn’t really presented in a fair and balanced manner, more than 90% of newborn stem cells are discarded as medical waste. There is only one chance to collect and store these stem cells, and that is immediately after birth. Expectant parents can either choose to store their child’s umbilical cord blood, or they can donate it to a public bank. As of now, only a select number of hospitals are able to collect the cord blood for storage in public cord blood banks.

A lot of parents don’t know that cord blood can have the potential for treatments and medical use that was not previously imagined. About 1/3 of parent’s comprehend that stem cells taken from umbilical cord blood are being used in regenerative and transplant medicine more often. Over the past 25 years cord blood stem cells have been used worldwide to treat nearly 80 serious diseases and disorders in adults and children.

The Family Cord Blood Banking Act has been introduced to Congress. This will ensure that cord blood banking services will be a qualified medical expense. For those people that believe in the continued study of stem cell research and want to provide their family with potential treatment options, cost should not be a barrier to preserve these unique, powerful cells.

BedJuddbabygirl Rebecca Judd paid $3000 to store her daughters umbilical cord blood. This is why. Rebecca and Chris Judd have decided to store their newborn daughter Billie Kate’s umbilical cord blood.

BedJuddbabygirl Rebecca Judd paid $3000 to store her daughters umbilical cord blood. This is why.
Rebecca and Chris Judd have decided to store their newborn daughter Billie Kate’s umbilical cord blood.

Australian model Rebecca Judd and her husband Australian Football League player Chris Judd have decided to store their newborn daughter Billie Kate’s umbilical cord blood.

The reason? They want to be prepared should there ever come a time when stem cells could help their family.

The 31-year-old mother reportedly made the decision to store the blood, as tissue from the umbilical cord contains haematopoietic stem cells (which can be used to treat immune system disorders and generate red blood cells) and mesenchymal stromal cells (which can be grown into bone and cartilage).

Chris Judd has suffered from knee problems in the past – so if either of his children suffer from the same issues, the solution may already be frozen and waiting for them.

After the birth of their first child, Oscar, born in 2011, the Judds chose to store only the cord blood – but this time Rebecca decided they should store the extra tissue.

She told the Herald Sun:

“It made a lot of sense to store both the cord tissue and blood with our new daughter … Of course, you obviously hope to never be in a position to have to use it. But ensuring we stored this important cord tissue and cord blood — when you have only one opportunity at birth — made sense.”

So what motivates a parent to look that far into the future, and think about storing umbilical cord blood and tissue – at the moment of giving birth?

rebecca judd cord blood 3 Rebecca Judd paid $3000 to store her daughters umbilical cord blood. This is why.
Two per cent of Aussie families made the decision to privately store cord blood last year.
While some might find the motivation a bit morbid – in the sense that you are storing the blood for the sole purpose of dealing with the possibility of leukaemia, anaemia and autoimmune diseases in the future – it’s actually quite a sensible idea.

The process is painless, and doesn’t hurt mother or child. After giving birth, an obstetrician will collect blood from the umbilical cord – which will then be transferred to cord blood bank for freezing.

Cell Care, the company which is storing the Judds’ cord blood tissue, has revealed to the Sun Herald that about two per cent of Aussie families made the decision to privately store cord blood last year.

Private cord blood banks mean that the parents have to pay a fee, and the cord is stored for exclusive use by the child (or related family members). There are also public donation banks, where parents can chooser to donate the cord blood which is then available to be used by anyone in Australia who is a suitable genetic match – much like a standard blood bank – which has the potential to save other lives.

Family Cord Blood Price & Accreditation Options

Family Cord Blood Price & Accreditation Options
The following table summarizes the banks in this country under these columns:
LABORATORY that the bank uses to process the cord blood.
ACCREDITATIONS held by the laboratory
THERAPIES from this lab - A number with NO "*" means the cord blood therapies were for private clients who had a family banking contract. A number with a "*" means the cord blood was listed on a public registry and released to a transplant patient outside the family. Some laboratories provide both types of storage.
COST ( YEAR ONE ) is the initial price of banking with this company.
COST ( YEAR 20 ) is the total price after 20 years of storage.

LISTS OF ACCREDITED BANKS
AABB

FACT

FDA

HTA
NAME LABORATORY ACCREDITATIONS THERAPIES COST (YEAR ONE) COST (YEAR 20)
CORD:USE CORD:USE, Orlando, FL AABB 307* $2145 $4520
VIACORD ViaCord, Hebron, KY AABB 260 $1945 $4320
LIFEBANKUSA LifebankUSA, Cedar Knolls, NJ AABB 35 $2175 $4550
MAZE NY Blood Center, NY, NY AABB, FACT 1 $1990 $1990
STEMCYTE StemCyte, Covina, CA AABB, FACT 1900* $1500 $3875
CRYO-CELL Cryo-Cell, Oldsmar, FL AABB, ISO 61 $1720 $4095
SAFETYCORD Community Blood Services, Montvale, NJ AABB 300* $2100 $4000
GENESIS BANK Cook General BioTechnology, Indianapolis, IN AABB 2 $1275 $3650
FAMILYCORD FamilyCord, Los Angeles, CA AABB 101* + 17 $2120 $4140
MIRACLECORD private lab AABB varies by lab $1595 $2925
CELEBRATION STEM CELL CENTRE Celebration Stem Cell Centre, Gilbert AZ AABB 0 $1975 $4350
NEW ENGLAND CORD BLOOD BANK New England CBB, Newton, MA AABB 12 $1375 $3170
GENECELL GeneCell, Miami, FL none yet 0 $1,795 $3,595
ALPHACORD multiple labs - see table on AlphaCord web site varies by lab varies by lab starts at $890 starts at $2955
AMERICORD REGISTRY Cook General BioTechnology, Indianapolis, IN AABB 2 $1998 $1998
ASSUREIMMUNE AssureImmune, Boca Raton, FL
CARICORD ClinImmune dba CariCord, Aurora, CO AABB ? $2,095 $4,495
CORCELL CorCell (CBAI), Las Vegas, NV AABB 11 $1975 $4350
CORD BLOOD REGISTRY CBR, Tucson, AZ AABB, ISO 9001:2008 204 $1995 $4465
CORD BLOOD SOLUTIONS Community Blood Services, Montvale, NJ
CORE23 BIOBANK Core23 BioBank, Springfield, MI none yet 0 $2300 $5625
FAMILY LINK Kosair Children's Hospital, Louisville, KY
GENECORD Located in Augusta, GA ISO 9001:2008 0 $2595 $2595
LIFEFORCE CRYOBANKS Lifeforce Cryobanks, Altamonte Springs, FL AABB 14* $1399 $3679
LIFELINE CRYOGENICS LifeLine, Stamford, CT AABB 1 $1350 $3535
LIFESOURCE CRYOBANK LifeSource, Covington, LA -- 0 $2300 $4675
NEOSTEM Progenitor Cell Therapy, Allendale, NJ AABB 108* $2225 $4600
NEW HOPE CBB Community Blood Services, Montvale, NJ
NUVACORD NETWORK Community Blood Services, Montvale, NJ AABB 300* $1500 ?
PACIFICORD PacifiCord, Irvine, CA AABB 0 $2300 $5000
SOUTHERN CORD Cook General BioTechnology, Indianapolis, IN AABB 0
STORK MEDICAL Community Blood Services, Montvale, NJ
UTAH CORD BANK Utah Cord Bank, Sandy, UT
XYTEX Xytex, Augusta, GA ISO 9001:2008 0 $1875 $3775

Last Modified: 12/29/2013 – Parent's Guide to Cord Blood Foundation © 2007 - 2014